Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 5.340 | 5.570 | 0.230 |
Shares | 94.670 | 94.670 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.773 | 21.770 |
Price to Book | 3.757 | 3.989 |
Price to Sales | 4.261 | 2.260 |
Price to Cash Flow | 15.346 | 16.880 |
Dividend Yield | 1.327 | 1.345 |
5 Years Earnings Growth | 7.564 | 11.341 |
Number of long holdings: 74
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Merck&Co | US58933Y1055 | 9.22 | 125.54 | +0.81% | |
AstraZeneca | GB0009895292 | 6.91 | 12,190.0 | +1.35% | |
Roche Holding Participation | CH0012032048 | 6.41 | 231.00 | +1.18% | |
Regeneron Pharma | US75886F1075 | 6.26 | 980.16 | +1.06% | |
Siemens Healthineers | DE000SHL1006 | 4.58 | 53.38 | -0.15% | |
Hologic | US4364401012 | 4.40 | 73.78 | +1.65% | |
Thermo Fisher Scientific | US8835561023 | 4.08 | 567.98 | +0.93% | |
Danaher | US2358511028 | 3.62 | 256.80 | +1.61% | |
Novartis | CH0012005267 | 3.55 | 92.96 | +1.90% | |
Merck | DE0006599905 | 3.48 | 166.50 | +1.12% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Cleome Index USA Equities I USD Acu | 2.46B | 5.52 | 6.61 | - | ||
Cleome Index USA Equities Z USD Acc | 2.46B | 6.76 | 10.40 | 12.02 | ||
RBC Lux GlblEqFocus Class C USD Cap | 1.75B | 1.00 | 6.13 | - | ||
RBC Lux GlblEqFocus Class B USD Cap | 1.75B | 0.96 | 6.02 | - | ||
RBC Lux GlblEqFocus Class A USD Cap | 1.75B | 0.54 | 4.97 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review